#United States #Robbins Geller #San Diego #Class Action #Baxter International

Baxter International, Inc. Investors Alert

Join the Class Action Lawsuit

Baxter International, Inc. (NYSE: BAX) is currently facing a significant legal challenge, as Robbins Geller Rudman & Dowd LLP invites investors who have experienced substantial losses since February 23, 2022, to participate in a class action lawsuit. This lawsuit, known as Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., highlights serious allegations against Baxter regarding misleading practices that may have led to considerable financial damage for its shareholders.

The Allegations: Systemic Defects and Misleading Statements

The class action lawsuit contends that Baxter’s Novum IQ Large Volume Pump, a critical healthcare device, suffered from systemic defects resulting in significant malfunctions. These defects, including underinfusion and overinfusion, potentially jeopardized patient health by exposing them to severe risks. Moreover, it claims that Baxter's management was aware of these issues yet failed to disclose them to investors, leading to misplaced confidence in the company's product reliability.

Baxter has also been accused of making inadequate attempts to rectify these problems. According to the allegations, their customer alerts regarding the malfunctions were insufficient and did not address the root causes of the defects. This negligence culminated in a notable impact on the company's reputation and stock price, which reportedly fell over 22% following public disclosure of the product issues on July 31, 2025.

The Path Forward for Investors

Investors holding Baxter stock during the class period have until December 15, 2025, to seek designation as lead plaintiff in the lawsuit. The position of lead plaintiff is crucial as this individual will represent all affected investors. The lead plaintiff is generally chosen based on their financial stake in the case and will guide the litigation process with the law firm of their choice.

It's important to note that an investor's likelihood of recuperating potential losses does not rely solely on acting as the lead plaintiff; all investors affected by the alleged misconduct can benefit from any resolution reached in the case.

About Robbins Geller Rudman & Dowd LLP

As one of the leading law firms in the field of securities litigation, Robbins Geller Rudman & Dowd LLP has a remarkable track record. They have consistently achieved significant recoveries for investors, including over $2.5 billion in 2024 alone. Their expertise in shareholder rights positions them as a formidable ally for those looking to recover losses from Baxter’s alleged misrepresentation.

For interested investors, more information can be found on their website at Robbins Geller’s Class Action Page. Potential plaintiffs are encouraged to reach out, with contact available via phone at 800-449-4900 or through email at [email protected].

Final Thoughts

As Baxter International, Inc. navigates this challenging period, affected investors should consider taking action promptly to ensure their rights are protected. With significant losses at stake, joining the class action lawsuit could provide an essential avenue for recovery.